騰訊(00700.HK)向外部資本派送快手(01024.HK)5,115萬股 持股降至約19%
騰訊(00700.HK)最近再減持重磅科企,快手(01024.HK)近日股權披露顯示,大股東騰訊旗下公司Parallel Nebula Investment Limited(PNI)向外部資本夥伴無償派送5,115萬股、市值逾26億元快手股份,不涉交易代價。減持後騰訊的快手持股由20.46%減至19.02%。騰訊減持約1.4%快手股權後,仍為快手單一最大股東。
騰訊於去年3月及今年3月,先後向股東派送京東及美團分別價值逾千億元的持股,現有港股上市科企投資中,以快手的持股價值最高;其次是閱文(00772.HK),騰訊持有逾56%股權,為其控股股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.